Please login to the form below

Not currently logged in
Email:
Password:

Roche sponsors smear test blog

Roche is supporting a UK-based blog aimed at helping overcome women's fears of cervical smear tests

Roche is sponsoring a blog which aims to encourage UK women to take a cervical smear test.

The blog, My Diary From Down Under, features no branding but visitors can read about Roche's newly-launched Cobas human papillomavirus (HPV) test. There is a disclaimer stating that the blogger is "working with" Roche and it also mentions the company's HPV test.

Healthcare writer and journalist Nikki Bayley will be tracking and blogging her journey of having a smear, from the moment she picks up the phone and makes an appointment, to receiving the results.

Paul Eros, director of molecular diagnostics at Roche, said: "Latest scientific research from around the world indicates that testing for HPV is a surer method of pinpointing high-risk cases of cervical pre-cancer since the virus is associated with 99.7 per cent of all cervical cancer."

"Currently, the screening programme does not test on a routine basis for the presence of HPV. Doing so could lead to better detection of those women at risk. Also, women who are not at risk benefit from attending screens less often, leading to cost and efficiency savings for the NHS."

Around 1,000 women die of cervical cancer in the UK each year. It is estimated that early detection through cervical screening and subsequent treatment can prevent up to 75 per cent of cervical cancers from developing in the UK.

The blog can be found at http://mydiaryfromdownunder.wordpress.com/

8th June 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics